The supernatants of dual-agent-treated HCC cells inhibited ERK phosphorylation and Fibronectin and α-SMA expression in HSCs, while rSDF-1α reversed these inhibitory effects (Figure 6F). The gene discussed is FN1; the disease is hepatocellular carcinoma.